Background: The aim of this study was to investigate cytological features of Brenner tumors according to tumor grade using imprint cytology. Case: Between 2004 and 2015, intraoperative imprint cytology was performed on 8 patients with Brenner tumors suspected to be malignant neoplasmas on gross examination because of their large size and solid part. These consisted of 1 benign, 3 borderline, and 4 malignant tumors. In patients with benign and borderline tumors, naked nucleus-like stromal cells and tumor cells in a sheet-like arrangement were observed against a clear background. The nuclei were round to oval-shaped with finely granular chromatin patterns and small nucleoli. Papillary cell clusters and high nucleus-to-cytoplasm ratios were only observed in 1 borderline case. In cases with malignancy, the background was necrotic. The tumor cells occurred in large papillary clusters. The nuclei showed a high degree of nuclear atypia. Nuclear grooves were present in 6 of our 8 cases and they were scant in the malignant cases. Conclusion: Imprint cytology of Brenner tumors provided no characteristic findings to enable a definitive distinction of benign versus borderline tumors, but it enabled discrimination between malignant and other tumors. Imprint cytology can facilitate intraoperative diagnosis and aid in selecting the appropriate surgical procedure.

Keywords:
Ovary, Brenner tumor, Imprint cytology
1.
Ilvan S, Ramazanoglu R, Ulker Akyildiz E, Calay Z, Bese T, Oruc N: The accuracy of frozen section (intraoperative consultation) in the diagnosis of ovarian masses. Gynecol Oncol 2005;97:395-399.
2.
Stewart CJ, Brennan BA, Hammond IG, Leung YC, McCartney AJ: Intraoperative assessment of ovarian tumors: a 5-year review with assessment of discrepant diagnostic cases. Int J Gynecol Pathol 2006;25:216-222.
3.
Rakhshan A, Zham H, Kazempour M: Accuracy of frozen section diagnosis in ovarian masses: experience at a tertiary oncology center. Arch Gynecol Obstet 2009;280:223-228.
4.
Akrivos N, Thomakos N, Sotiropoulou M, Rodolakis A, Antsaklis A: Intraoperative consultation in ovarian pathology. Gynecol Obstet Invest 2010;70:193-199.
5.
Alvarez Santín C, Sica A, Melesi S, Feijó A, Garrido G, Rodríguez Alvarez C: Contribution of intraoperative cytology to the diagnosis of ovarian lesions. Acta Cytol 2011;55:85-91.
6.
Nakamura J, Torii Y, Nishikawa R, Yamamoto T, Nishigami T, Ogasawara T, Hao H, Hirota S: Cytological comparison in various subtypes of four Brenner tumors. J Jpn Soc Clin Cytol 2007;46:370-376.
7.
Omori M, Kondo T, Hashi A, Ishii Y, Nakazawa K, Fukasawa H, Katoh R, Hirata S: Cytological features of transitional cell tumors of the ovary. J Jpn Soc Clin Cytol 2014;53:323-328.
8.
Singh RI, Rosen L, Reddy VB, Bitterman P, Stemm MH, Gattuso P: Intraoperative imprint cytology of ovarian transitional cell (Brenner) tumors: a retrospective study. Diagn Cytopathol 2014;42:660-663.
9.
Nagai Y, Tanaka N, Horiuchi F, Ohki S, Seki K, Sekiya S: Diagnostic accuracy of intraoperative imprint cytology in ovarian epithelial tumors. Int J Gynaecol Obstet 2001;72:159-164.
10.
Khunamornpong S, Siriaunkgul S: Scrape cytology of the ovaries: potential role in intraoperative consultation of ovarian lesions. Diagn Cytopathol 2003;28:250-257.
11.
Dey S, Misra V, Singh PA, Mishra S, Sharma N: Role of intraoperative imprint cytology in diagnosis of suspected ovarian neoplasms. Asian Pac J Cancer Prev 2010;11:1389-1391.
12.
Abe A, Sugiyama Y, Furuta R, Furuta N, Matoda M, Takeshima N: Usefulness of intraoperative imprint cytology in ovarian germ cell tumors. Acta Cytol 2013;57:171-176.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.